Pricing Log in Create free account

Erasca, Inc. (ERAS) vs Legend Biotech Corporation Sponsored ADR (LEGN)

Erasca, Inc. and Legend Biotech Corporation Sponsored ADR are both Biotechnology companies. Erasca, Inc. and Legend Biotech Corporation Sponsored ADR are of similar size ($4.6B and $4.4B). Erasca, Inc. has the higher net margin (0.00% vs −7.20%) and the lower return on invested capital (−203.1% vs −9.54%). Across the 14 metrics below, Erasca, Inc. leads on 7 and Legend Biotech Corporation Sponsored ADR on 7.

Valuation

Metric ERAS LEGN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 3.45 9.40
P/B 12.34 3.57 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 2.95 9.02
Earnings yield (6.62%) (2.11%) (32.88%)
Free cash flow yield (5.65%) (2.79%) (23.13%)

Profitability

Metric ERAS LEGN Biotechnology median
Gross margin 0.00% 56.58% 68.51%
Operating margin 0.00% (5.06%) 0.00%
Net margin 0.00% (7.20%) 0.00%
Free cash flow margin 0.00% (9.58%) 0.00%
Return on equity (78.25%) (8.08%) (51.96%)
Return on assets (65.25%) (5.32%) (46.06%)
Return on invested capital (203.13%) (9.54%) 0.00%

Growth

Metric ERAS LEGN Biotechnology median
Revenue growth (TTM) — 59.55% 6.76%
EPS growth (last fiscal year) 36.23% (66.34%) 29.88%
Revenue growth, 5-year CAGR — 65.93% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERAS LEGN Biotechnology median
Debt to equity 0.00 0.13 0.00
Current ratio 8.29 3.04 4.97
Net debt to EBITDA 1.93 2.31 1.01

Dividend

Metric ERAS LEGN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ERAS LEGN Biotechnology median
Market cap 4.64b 4.37b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack